Literature DB >> 23652203

Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling.

Shingo Mutoh1, Mack Sobhany, Rick Moore, Lalith Perera, Lee Pedersen, Tatsuya Sueyoshi, Masahiko Negishi.   

Abstract

Phenobarbital is a central nervous system depressant that also indirectly activates nuclear receptor constitutive active androstane receptor (CAR), which promotes drug and energy metabolism, as well as cell growth (and death), in the liver. We found that phenobarbital activated CAR by inhibiting epidermal growth factor receptor (EGFR) signaling. Phenobarbital bound to EGFR and potently inhibited the binding of EGF, which prevented the activation of EGFR. This abrogation of EGFR signaling induced the dephosphorylation of receptor for activated C kinase 1 (RACK1) at Tyr(52), which then promoted the dephosphorylation of CAR at Thr(38) by the catalytic core subunit of protein phosphatase 2A. The findings demonstrated that the phenobarbital-induced mechanism of CAR dephosphorylation and activation is mediated through its direct interaction with and inhibition of EGFR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652203      PMCID: PMC5573139          DOI: 10.1126/scisignal.2003705

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  32 in total

1.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

2.  Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene.

Authors:  T Kawamoto; T Sueyoshi; I Zelko; R Moore; K Washburn; M Negishi
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Insulin induces swelling-dependent activation of the epidermal growth factor receptor in rat liver.

Authors:  Roland Reinehr; Annika Sommerfeld; Dieter Häussinger
Journal:  J Biol Chem       Date:  2010-06-22       Impact factor: 5.157

4.  Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm.

Authors:  Makoto Osabe; Masahiko Negishi
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

5.  The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice.

Authors:  Yukio Yamamoto; Rick Moore; Thomas L Goldsworthy; Masahiko Negishi; Robert R Maronpot
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

Review 6.  PXR and CAR in energy metabolism.

Authors:  Taira Wada; Jie Gao; Wen Xie
Journal:  Trends Endocrinol Metab       Date:  2009-08       Impact factor: 12.015

7.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.

Authors:  D A Tice; J S Biscardi; A L Nickles; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

9.  Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase.

Authors:  Patrick A Kiely; George S Baillie; Robert Barrett; Deirdre A Buckley; David R Adams; Miles D Houslay; Rosemary O'Connor
Journal:  J Biol Chem       Date:  2009-05-07       Impact factor: 5.157

10.  Independent mechanisms for tumor promoters phenobarbital and 12-O-tetradecanoylphorbol-13-acetate in reduction of epidermal growth factor binding by rat hepatocytes.

Authors:  S A Meyer; T A Gibbs; R L Jirtle
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

View more
  77 in total

1.  Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine.

Authors:  Devinder Sharma; Aik Jiang Lau; Matthew A Sherman; Thomas K H Chang
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

2.  Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.

Authors:  Ryota Shizu; Makoto Osabe; Lalith Perera; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

Review 3.  Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.

Authors:  Susumu Kodama; Masahiko Negishi
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

4.  Widespread epigenetic changes to the enhancer landscape of mouse liver induced by a specific xenobiotic agonist ligand of the nuclear receptor CAR.

Authors:  Andy Rampersaud; Nicholas J Lodato; Aram Shin; David J Waxman
Journal:  Toxicol Sci       Date:  2019-06-24       Impact factor: 4.849

5.  Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation.

Authors:  Takuyu Hashiguchi; Shingo Arakawa; Shogo Takahashi; Frank J Gonzalez; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Endocrinol       Date:  2016-08-29

Review 6.  The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

Authors:  Bryan Mackowiak; Jessica Hodge; Sydney Stern; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2018-05-14       Impact factor: 3.922

7.  Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes.

Authors:  Tatsuya Sueyoshi; Linhao Li; Hongbing Wang; Rick Moore; Prasada Rao S Kodavanti; Hans-Joachim Lehmler; Masahiko Negishi; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2013-11-11       Impact factor: 4.849

8.  Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture.

Authors:  Banrida Wahlang; K Cameron Falkner; Heather B Clair; Laila Al-Eryani; Russell A Prough; J Christopher States; Denise M Coslo; Curtis J Omiecinski; Matthew C Cave
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

9.  Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptor.

Authors:  Norie Murayama; Rinie van Beuningen; Hiroshi Suemizu; Christiane Guguen Guillouzo; Norio Shibata; Kanako Yajima; Masahiro Utoh; Makiko Shimizu; Christophe Chesné; Masato Nakamura; F Peter Guengerich; René Houtman; Hiroshi Yamazaki
Journal:  Chem Res Toxicol       Date:  2014-02-05       Impact factor: 3.739

10.  Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis.

Authors:  Lawrence A Scheving; Xiuqi Zhang; Mary C Stevenson; Michael A Weintraub; Annam Abbasi; Andrea M Clarke; David W Threadgill; William E Russell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-22       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.